Three days after the U.S. Supreme Court struck down Roe v. Wade in one of the most potentially impactful rulings of the last century, a handful of women's health stocks are on the move on Monday in response to the news.
Stocks On The Move: Evofem Biosciences Inc (NASDAQ:EVFM) shares ripped higher by more than 133% on Monday morning. Evofem's Phexxi vaginal gel is a contraceptive that can be applied zero to 60 minutes prior to each act of intercourse. Phexxis is a combination of lactic acid, citric acid and potassium bitartrate and is the first and only hormone-free, on-demand prescription contraceptive vaginal gel.
